Abstract |
We studied blood pressure (BP) and heart rate (HR) responses in 12 patients with hypertension who were receiving cetamolol, a cardioselective beta-blocker with intrinsic sympathomimetic activity. The BP and HR parameters were evaluated at rest (casual, office readings), with ambulatory BP monitoring, and after treadmill exercise testing. At a mean (+/- SD) dose of 46 +/- 21 mg/day, casual supine BP decreased by 10/12 mm Hg (P less than 0.05 for systolic; P less than 0.01 for diastolic) compared with placebo, while HR decreased 4 bpm. Cetamolol resulted in a significant reduction in the mean 24-hour systolic BP. The most striking reduction occurred in the BP at work (23 mm Hg), with almost no decrease in the BP during sleep. Ambulatory HR reductions occurred while the subjects were at work (9 bpm; P less than 0.05) but not while at home (awake) or during sleep. The mean duration of exercise was the same during cetamolol and placebo phases, but both HR and BP fell significantly at peak performance after cetamolol. These data suggest that cetamolol reduces BP without lowering HR at rest. During periods of increased adrenergic activity such as work and dynamic exercise, both HR and BP are reduced.
|
Authors | W B White, P Schulman, E J McCabe, W D Hager |
Journal | Clinical pharmacology and therapeutics
(Clin Pharmacol Ther)
Vol. 39
Issue 6
Pg. 664-8
(Jun 1986)
ISSN: 0009-9236 [Print] United States |
PMID | 3709031
(Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Acetamides
(pharmacology, therapeutic use)
- Adult
- Blood Pressure
(drug effects)
- Electrocardiography
- Female
- Heart Rate
(drug effects)
- Humans
- Hypertension
(drug therapy)
- Male
- Middle Aged
- Physical Exertion
- Posture
- Rest
|